Back
Rapport Therapeutics, Inc. Common Stock RAPP · Insights
Rapport Therapeutics, Inc. functions as a clinical-phase biopharmaceutical enterprise, concentrating... Price26.07
Market Cap1.53 B
Float33.91 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro